It wasn't blood transfusions that "gave him an unfair advantage"; it was the (medically necessary) EPO treatments he received while undergoing chemotherapy.
Those specific complaints/allegations were ignored, however, because the effects of EPO don't last more than a few weeks, and it was well more than a year between the last of his (medically necessary) EPO treatments in late 1996/early 1997 and his return to competition in spring 1998.




Reply With Quote